Abstract:While originally identified as an antiviral pathway, recent work has implicated cyclic GMP-AMP-synthase-Stimulator of Interferon Genes (cGAS-STING) signaling as playing a critical role in the neuroinflammatory response to traumatic brain injury (TBI). STING activation results in a robust inflammatory response characterized by the production of inflammatory cytokines called interferons, as well as hundreds of interferon stimulated genes (ISGs). Global knockout (KO) mice inhibiting this pathway display neuroprotection with evidence that this pathway is active days after injury; yet, the early neuroinflammatory events stimulated by STING signaling remain understudied. Furthermore, the source of STING signaling during brain injury is unknown. Using a murine controlled cortical impact (CCI) model of TBI, we investigated the peripheral immune and microglial response to injury utilizing male chimeric and conditional STING KO animals, respectively. We demonstrate that peripheral and microglial STING signaling contribute to negative outcomes in cortical lesion volume, cell death, and functional outcomes post injury. A reduction in overall peripheral immune cell and neutrophil infiltration at the injury site is STING dependent in these models at 24 hours. Transcriptomic analysis at 2 hours, when STING is active, reveals that microglia drive an early, distinct transcriptional program to elicit proinflammatory genes including interleukin 1-beta (IL-1β), which is lost in conditional knockout mice. The upregulation of alternative innate immune pathways also occurs after injury in these animals, which supports a complex relationship between brain-resident and peripheral immune cells to coordinate the proinflammatory response and immune cell influx to damaged tissue after injury. Significance Statement The innate immune STING pathway triggers harmful neuroinflammation after traumatic brain injury with support from human and preclinical models indicating that this pathway is active hours to days after injury. Our findings in a preclinical cortical contusion model suggest that STING signaling specifically from peripheral immune cells or microglia drive this process to affect injury outcome. Activation of STING in microglia as early as 2 hours post-injury drives a distinct transcriptional program that influences neutrophil and peripheral immune cell influx, which dictates injury outcomes. These findings shed light on the acute temporal changes in a cell-type specific manner where innate immunity drives subsequent events that affect secondary injury processes after insult.

Emerging role of STING signalling in CNS injury: inflammation, autophagy, necroptosis, ferroptosis and pyroptosis

The role of STING signaling in central nervous system infection and neuroinflammatory disease

cGAS-STING signaling pathway in gastrointestinal inflammatory disease and cancers

Mechanism and therapeutic potential of targeting cGAS-STING signaling in neurological disorders

Cellular functions of cGAS-STING signaling

cGAS- Stimulator of Interferon Genes Signaling in Central Nervous System Disorders

STING-dependent signaling in microglia or peripheral immune cells orchestrates the early inflammatory response and influences brain injury outcome

cGAS-STING-mediated IFN-I Response in Host Defense and Neuroinflammatory Diseases

STING signaling in the brain: Molecular threats, signaling activities, and therapeutic challenges

The emerging role of stimulator of interferons genes signaling in sepsis: Inflammation, autophagy, and cell death

cGAS-STING-mediated IFNI Response in Host Defense and Neuroinflammatory Diseases

Novel insight into cGAS-STING pathway in ischemic stroke: from pre- to post-disease

The cytosolic DNA‐sensing cGAS–STING pathway in neurodegenerative diseases

The Cgas-Sting Pathway Drives Neuroinflammation and Neurodegeneration Via Cellular and Molecular Mechanisms in Neurodegenerative Diseases

Type I Interferon Response Is Mediated by NLRX1-cGAS-STING Signaling in Brain Injury

cGAS-STING signaling in cardiovascular diseases

Inhibition of the cGAS-STING pathway: contributing to the treatment of cerebral ischemia/reperfusion injury

IUPHAR ECR review: The cGAS-STING pathway: Novel functions beyond innate immune and emerging therapeutic opportunities

Relationship between the cGAS−STING and NF-κB pathways-role in neurotoxicity

Abstract Sa603: Inhibiting the Activation of Cgas-Sting Signaling Pathway Can Improve Brain Injury after Cardiopulmonary Resuscitation

Mechanism and effects of STING-IFN-I pathway on nociception: A narrative review.